Beam Therapeutics, Inc. (BEAM)

28.46 -0.46 (-1.59%) USD  |  NASDAQ  |  Feb 27, 16:00
27.60 -0.86 (-3.02%) Pre-Market: 09:25
More

Beam Therapeutics Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for BEAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Twist Bioscience Corp. Upgrade
Pacific Biosciences of California, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Stryker Corp. Upgrade
Zimmer Biomet Holdings, Inc. Upgrade